In the ever-evolving realm of modern medicine, a once-distant dream to conquer disease through genetics has now inched closer to reality. Last Friday, the U.S. Food and Drug Administration approved ...
The European Union on Tuesday approved the world’s first medicine based on CRISPR gene-editing technology to treat two blood disorders, following the U.S. and U.K. in a milestone for the revolutionary ...
Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...